Capital Fund Management (CFM)
TVTX icon

Capital Fund Management (CFM)’s Travere Therapeutics TVTX Stock Holding History

Capital Fund Management (CFM)’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.55M Buy
+85,881
New +$2.57M 0.01% 1242
2025
Q4 		– Sell
-41,512
Closed -$992K – 2675
2025
Q3 		$992K Sell
41,512
-59,894
-59% -$1.13M ﹤0.01% 2106
2025
Q2 		$1.5M Buy
+101,406
New +$1.68M ﹤0.01% 1824
2023
Q3 		– Sell
-43,824
Closed -$673K – 2098
2023
Q2 		$673K Buy
+43,824
New +$797K ﹤0.01% 1512

Other funds holding TVTX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Capital Fund Management (CFM)'s TVTX Position: Q1 2026 in Review

Capital Fund Management (CFM) opened a new position in Travere Therapeutics (TVTX) in Q1 2026: 85,881 shares worth $2.55M. The stake represents 0.01% of the portfolio and ranks #1242 among its holdings. This is a return to the name: Capital Fund Management (CFM) previously reported a position in TVTX as recently as Q3 2025.

Capital Fund Management (CFM) first reported a position in TVTX in Q2 2023 and has held it in 4 quarters since. 260 funds tracked by Wall St. Rank hold TVTX as of Q1 2026.

  • Capital Fund Management (CFM) held 85,881 shares of Travere Therapeutics worth $2.55M as of Q1 2026.
  • Travere Therapeutics was a new Capital Fund Management (CFM) position in Q1 2026.
  • Travere Therapeutics made up 0.01% of Capital Fund Management (CFM)'s portfolio in Q1 2026, its #1242 holding.
  • Capital Fund Management (CFM) first reported a position in Travere Therapeutics in Q2 2023 and has held it in 4 quarters since.
  • 260 funds tracked by Wall St. Rank held Travere Therapeutics as of Q1 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2026, filed 14 May 2026.